NEW YORK, March 23, 2017 /PRNewswire/ --
Focus today is on Healthcare Facilities REITs, which own and operate propertiesincluding hospitals, senior housing facilities, skilled nursing facilities, and other medical office buildings. These companies also tend to offer dividend yields that are well above the wider market average. Pre-market, Stock-Callers.com observes the
Irvine, California-based HCP Inc.'s shares gained 1.60%, closing Wednesday's trading session at $30.49. The stock recorded a trading volume of 7.02 million shares, which was above its three months average volume of 4.00 million shares. The Company's shares have advanced 1.85% over the previous three months and 3.84% since the start of this year. The stock is trading 0.08% below its 50-day moving average. Additionally, shares of HCP, which invests in real estate markets of the US, have a Relative Strength Index (RSI) of 48.95.
On March 20th, 2017, HCP announced that a lawsuit is pending in Ohio for certain purchasers of the Company's shares over its alleged Securities Laws Violations. Investors, who purchased HCP's shares in February 2015 or earlier, and currently hold any of those shares, have certain options and should contact the Shareholders Foundation at mail.shareholdersfoundation.com.
On March 20th, 2017, research firm Morgan Stanley upgraded the Company's stock rating from 'Underweight' to 'Equal-Weight'. See our free and comprehensive research report on HCP at:
Medical Properties Trust
On Wednesday, shares in Birmingham, Alabama-based Medical Properties Trust Inc. recorded a trading volume of 4.70 million shares, which was above their three months average volume of 3.34 million shares. The stock rose 1.54%, ending the day at $12.52. The Company's shares have advanced 3.89% in the last three months and 3.81% over the previous one year. The stock is trading below its 50-day moving average by 0.60%. Furthermore, shares of Medical Properties Trust, which operates as a REIT in the US, have an RSI of 50.51.
On March 15th, 2017, Medical Properties Trust reported that the previously announced public offering of €500 million aggregate principal amount of senior notes due 2025 by its operating partnership, MPT Operating Partnership, L.P. and MPT Finance Corporation, priced on Match 15th with a coupon of 3.325%. Offering of the Notes is expected to close on or about March 24th, 2017, subject to certain closing conditions.
On March 10th, 2017, research firm Robert W. Baird initiated an 'Outperform' rating on the Company's stock, with a target price of $14 per share. MPW free research report PDF is just a click away at:
Toledo, Ohio-based Welltower Inc.'s stock finished the day 1.24% higher at $68.66 with a total trading volume of 1.74 million shares. The Company's shares have advanced 2.57% in the last one month, 4.81% in the previous three months, and 3.95% on an YTD basis. The stock is trading above its 50-day moving average by 2.89%. Additionally, shares of Welltower, which engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets, have an RSI of 58.47.
On February 22nd, 2017, Welltower announced a strategic collaboration with Johns Hopkins Medicine intended to promote innovative care and wellness for the aging population and to create programs that increase quality, value, and connectivity across the health care continuum.
On March 20th, 2017, research firm Morgan Stanley upgraded the Company's stock rating from 'Equal-Weight' to 'Overweight'. Sign up for your complimentary report on HCN at:
Shares in Maryland, US-based Omega Healthcare Investors Inc. ended yesterday's session 1.50% higher at $31.71. The stock recorded a trading volume of 1.31 million shares. The Company's shares have advanced 2.98% over the previous three months and 3.41% since the start of this year. The stock is trading 0.49% below its 50-day moving average. Moreover, shares of Omega Healthcare Investors, which invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio, have an RSI of 49.45.
On February 08th, 2017, Omega Healthcare released its Q4 2016 financial results, posting operating revenues for the three-month period ended December 31st, 2016, of $234.5 million compared to operating revenues of $210.5 million for Q4 2015. The Company also reported net income of $129.9 million, or $0.63 per common share, compared to net income of $63.5 million, or $0.32 per common share, for Q4 2015. Register for free on Stock-Callers.com and download the latest research report on OHI at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...
Unintended pregnancies are very common these days, and so one in about four pregnant women go for ...View All